Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (18)

2019

  1. Preventing bronchopulmonary dysplasia: new tools for an old challenge

    Pediatric Research, Vol. 85, Núm. 4, pp. 432-441

2018

  1. Care of the newborn with perinatal asphyxia candidate for therapeutic hypothermia during the first six hours of life in Spain

    Anales de Pediatria, Vol. 89, Núm. 4, pp. 211-221

2017

  1. The economic impact of prematurity and bronchopulmonary dysplasia

    European Journal of Pediatrics, Vol. 176, Núm. 12, pp. 1587-1593

2014

  1. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

    Epilepsia, Vol. 55, Núm. 6, pp. 791-802

  2. Estrategias de neuroprotección en el recién nacido

    Anales de Pediatria Continuada, Vol. 12, Núm. 2, pp. 85-89

2013

  1. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?

    British Journal of Clinical Pharmacology, Vol. 75, Núm. 2, pp. 323-333

  2. Cannabinoids: Well-Suited candidates for the treatment of perinatal brain injury

    Brain Sciences, Vol. 3, Núm. 3, pp. 1043-1059

  3. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors

    Neuropharmacology, Vol. 71, pp. 282-291

2012

  1. β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors

    British Journal of Pharmacology, Vol. 166, Núm. 4, pp. 1474-1489

2011

  1. Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs

    Pediatric Research, Vol. 70, Núm. 3, pp. 272-277

  2. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: An intravital microscopy study

    Journal of Neuroinflammation, Vol. 8

2010

  1. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia

    Stroke, Vol. 41, Núm. 12, pp. 2956-2964

  2. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs

    Brain Research, Vol. 1362, pp. 150-159

  3. The endocannabinoid system and amyloid-related diseases

    Experimental Neurology, Vol. 224, Núm. 1, pp. 66-73

  4. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2 and adenosine receptors

    Neurobiology of Disease, Vol. 37, Núm. 2, pp. 434-440

2009

  1. Cannabinoids and neurodegenerative diseases

    CNS and Neurological Disorders - Drug Targets, Vol. 8, Núm. 6, pp. 440-450

1998

  1. Endothelial factors and autoregulation during pressure changes in isolated newborn piglet cerebral arteries

    Pediatric Research, Vol. 44, Núm. 2, pp. 161-167

1996

  1. Impairment of acetylcholine relaxations by malondialdehyde, a marker of lipid peroxidation

    Journal of Vascular Research, Vol. 33, Núm. 6, pp. 463-470